Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

Edwards Lifesciences Corporation (EW) had Revenue of $1.41B for the most recently reported fiscal quarter, ending 2025-03-31.

Quarterly Annual

Figures for fiscal quarter ending 2025-03-31

Income Statement Financials
Revenue	$1.41B
Net Income	$358.00M
Cost of Goods Sold	$301.60M
Gross Profit	$1.11B
Operating Expenses	$1.02B
Operating Income	$394.80M
Non-Operating Income/Expense	$39.10M
Pre-Tax Income	$433.90M
Normalized Pre-Tax Income	$433.90M
Income after Taxes	$363.60M
Income from Continuous Operations	$363.60M
Consolidated Net Income/Loss	$356.40M
Normalized Income after Taxes	$363.60M
EBIT	$394.80M
EBITDA	$431.40M
Weighted-Average Shares Outstanding (Basic)	586.90M
Weighted-Average Shares Outstanding (Diluted)	587.80M
Earnings per Share (EPS) (Basic)	$0.61
Earnings per Share (EPS) (Diluted)	$0.61
Balance Sheet Financials
Current Assets	$6.21B
Property, Plant, and Equipment	$1.70B
Long-Term Assets	$6.81B
Total Assets	$13.02B
Current Liabilities	$1.39B
Long-Term Debt	$597.80M
Long-Term Liabilities	$1.44B
Total Liabilities	$2.83B
Common Equity	$10.19B
Tangible Shareholders Equity	$7.24B
Shareholders Equity	$10.19B
Common Shares Outstanding	586.20M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$280.40M
Cash Flow from Investing Activities	$85.30M
Cash Flow from Financial Activities	$-258.00M
Beginning Cash	$3.06B
End Cash	$3.15B
Increase/Decrease in Cash	$90.00M
Stock-Based Compensation	$40.20M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	4.45
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.06
Debt to Equity Ratio	0.06
Gross Margin	78.65%
Operating Margin	27.95%
EBIT Margin	27.95%
EBITDA Margin	--
Pre-Tax Profit Margin	30.71%
Profit Margin	25.34%
Free Cash Flow	$224.40M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.11
Inventory Turnover	0.27
Receiveable Turnover	1.88
Days Sales in Receivables	47.90
Return on Equity	3.57%
Return on Tangible Equity	5.02%
Return on Assets	2.79%
Return on Investments	3.37%
Book Value Per Share	$17.39
Free Cash Flow per Share	$0.38
Operating Cash Flow per Share	$0.48

Data from Zacks Investment Research, Inc.